Biolargo, Inc.

Biolargo, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.

Company Details

Employees
22
Founded
-
Address
14921 Chestnut St, Westminster,california 92683,united States
Phone
(949)643-9540
Email
In****@****rgo.com
Industry
Environmental Services
NAICS
Environmental Consulting Services
HQ
Westminster, California
Looking for a particular Biolargo, Inc. employee's phone or email?

Biolargo, Inc. Questions

News

BioLargo Presentation Deck at LD Micro Event Available Online - Newswire.com

BioLargo Presentation Deck at LD Micro Event Available Online Newswire.com

BioLargo (OTCQX: BLGO) files Form 8-K; LD Micro deck on Cellinity battery cell technology - Stock Titan

BioLargo (OTCQX: BLGO) files Form 8-K; LD Micro deck on Cellinity battery cell technology Stock Titan

BioLargo Protects its Intellectual Property, Revokes Pooph License Due to Failure to Pay and Other Contract Breaches - The Courier-Journal

BioLargo Protects its Intellectual Property, Revokes Pooph License Due to Failure to Pay and Other Contract Breaches The Courier-Journal

Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation - ACCESS Newswire

Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation ACCESS Newswire

BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT - The Globe and Mail

BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT The Globe and Mail

BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion - Newswire.com

BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion Newswire.com

16th Annual Energy Event: BioLargo Sponsors Sustain SoCal Conference Oct 16, 2025 in Irvine - Stock Titan

16th Annual Energy Event: BioLargo Sponsors Sustain SoCal Conference Oct 16, 2025 in Irvine Stock Titan

BioLargo Provides 2024 Review and 2025 Outlook - Yahoo Finance

BioLargo Provides 2024 Review and 2025 Outlook Yahoo Finance

BioLargo CEO Dennis Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee - citybiz

BioLargo CEO Dennis Calvert Appointed to U.S. Department of Commerce Environmental Technologies Trade Advisory Committee citybiz

BioLargo's Medical Tech Reaches 6,100 US Hospitals as Battery Division Signs Four Factory Deals - Stock Titan

BioLargo's Medical Tech Reaches 6,100 US Hospitals as Battery Division Signs Four Factory Deals Stock Titan

BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time - FinancialContent

BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time FinancialContent

BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology - Newswire.com

BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology Newswire.com

$50M Annual Sales Product Line Halted: BioLargo Revokes Pooph's License Over $3.8M Payment Dispute - Stock Titan

$50M Annual Sales Product Line Halted: BioLargo Revokes Pooph's License Over $3.8M Payment Dispute Stock Titan

BioLargo Gets Green Light for Reverse Split, Reveals Strategic Nasdaq Uplisting Plan Instead - Stock Titan

BioLargo Gets Green Light for Reverse Split, Reveals Strategic Nasdaq Uplisting Plan Instead Stock Titan

99% Removal of "Forever Chemicals": BioLargo's Tech Breakthrough Tackles Hardest PFAS Challenge - Stock Titan

99% Removal of "Forever Chemicals": BioLargo's Tech Breakthrough Tackles Hardest PFAS Challenge Stock Titan

BioLargo’s AEC technology breaks new ground in PFAS water treatment - Innovation News Network

BioLargo’s AEC technology breaks new ground in PFAS water treatment Innovation News Network

BioLargo Provides Review of 2025 Accomplishments and Insights for Coming Year - ACCESS Newswire

BioLargo Provides Review of 2025 Accomplishments and Insights for Coming Year ACCESS Newswire

BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements - FinancialContent

BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements FinancialContent

BioLargo Begins Next Step in Preparing Garratt-Callahan Minimal Liquid Discharge System for Commercial Launch - The Globe and Mail

BioLargo Begins Next Step in Preparing Garratt-Callahan Minimal Liquid Discharge System for Commercial Launch The Globe and Mail

Top Biolargo, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant